PENS Device Cleared To Treat Pain Following C-Section Delivery
Approval was based on a prospective study that included 44 participants who underwent C-section delivery.
Diagnosis & Disease Information
Glycopyrrolate Injection 0.6 mg/3 mL Now Available in Ready-to-Administer, Prefilled Syringe
The Simplist ready-to-administer prefilled syringes minimize preparation steps for clinicians.
Oral NaV1.8 Inhibitor VX-548 Designated Breakthrough Therapy for Severe Acute Pain
The designation was based on data from two phase 2 proof-of-concept studies that evaluated VX-548 for acute pain following abdominoplasty or bunionectomy surgery.
Opioid Denials Lead to Rise in Violent Attacks on Pain and Addiction Experts
Pain and addiction specialists discuss the rise in workplace violence related to opioid denials and how to improve communication and change patient expectations.
Topical Amitriptyline Gets Fast Track Status for Chemotherapy-Induced Neuropathic Pain
ATX01 is a topical formulation of amitriptyline designed to directly inhibit pain signaling in the nerve fibers on the epidermis and dermis.
FDA to Review Intranasal Zavegepant for Migraine Treatment
The NDA submission includes data from 2 pivotal studies that evaluated zavegepant in adults with at least a 1-year history of migraine and migraine attacks.
Gabapentin-Involved Overdose Deaths Increased Between 2019 and 2020
Researchers used data from the State Unintentional Drug Overdose Reporting System in order to assess trends in gabapentin-involved overdose deaths.
FDA Considers Mail-Back Envelope as New Disposal Method for Opioids
The Agency is currently seeking public comment on this potential modification to the existing Opioid Analgesic Risk Evaluation and Mitigation Strategy.
Nitrosamine Impurity Detected in Certain Lots of Orphenadrine Citrate ER Tablets
Orphenadrine citrate ER tablet is indicated as an adjunct to rest, physical therapy and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions.
Novel Sciatica Treatment Provides Significant Pain Relief in Phase 3 Trial
SP-102 is a dexamethasone sodium phosphate viscous gel formulation that is administered by epidural injection.
- Loading...
Loading...
Next post in News
Loading... 
Loading...